USANA HEALTH SCIENCES INC (USNA) Fundamental Analysis & Valuation
NYSE:USNA • US90328M1071
17.385 USD
+0.18 (+1.02%)
Last: Mar 13, 2026, 09:45 AM
This USNA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
We assign a fundamental rating of 5 out of 10 to USNA. USNA was compared to 37 industry peers in the Personal Care Products industry. USNA has an excellent financial health rating, but there are some minor concerns on its profitability. USNA has a correct valuation and a medium growth rate.
1. USNA Profitability Analysis
1.1 Basic Checks
- USNA had positive earnings in the past year.
- USNA had a positive operating cash flow in the past year.
- USNA had positive earnings in each of the past 5 years.
- USNA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- USNA has a Return On Assets (2.34%) which is in line with its industry peers.
- Looking at the Return On Equity, with a value of 3.22%, USNA is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 5.43%, USNA is in line with its industry, outperforming 59.46% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for USNA is in line with the industry average of 11.32%.
- The last Return On Invested Capital (5.43%) for USNA is well below the 3 year average (9.82%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROIC | 5.43% |
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
1.3 Margins
- Looking at the Profit Margin, with a value of 1.86%, USNA is in line with its industry, outperforming 59.46% of the companies in the same industry.
- In the last couple of years the Profit Margin of USNA has declined.
- USNA's Operating Margin of 4.58% is in line compared to the rest of the industry. USNA outperforms 56.76% of its industry peers.
- USNA's Operating Margin has declined in the last couple of years.
- USNA's Gross Margin of 79.18% is amongst the best of the industry. USNA outperforms 94.59% of its industry peers.
- USNA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% |
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
2. USNA Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), USNA is creating some value.
- The number of shares outstanding for USNA has been reduced compared to 1 year ago.
- Compared to 5 years ago, USNA has less shares outstanding
- USNA has a better debt/assets ratio than last year.
2.2 Solvency
- USNA has an Altman-Z score of 3.54. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
- USNA's Altman-Z score of 3.54 is fine compared to the rest of the industry. USNA outperforms 75.68% of its industry peers.
- There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.54 |
ROIC/WACC0.64
WACC8.55%
2.3 Liquidity
- A Current Ratio of 2.23 indicates that USNA has no problem at all paying its short term obligations.
- USNA has a Current ratio (2.23) which is in line with its industry peers.
- USNA has a Quick Ratio of 1.46. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
- USNA has a Quick ratio (1.46) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 |
3. USNA Growth Analysis
3.1 Past
- USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.15%.
- Measured over the past years, USNA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.00% on average per year.
- Looking at the last year, USNA shows a quite strong growth in Revenue. The Revenue has grown by 8.28% in the last year.
- USNA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
3.2 Future
- USNA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.31% yearly.
- Based on estimates for the next years, USNA will show a small growth in Revenue. The Revenue will grow by 4.02% on average per year.
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. USNA Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 9.05 indicates a reasonable valuation of USNA.
- Compared to the rest of the industry, the Price/Earnings ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 81.08% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 25.71, USNA is valued rather cheaply.
- With a Price/Forward Earnings ratio of 8.52, the valuation of USNA can be described as very reasonable.
- USNA's Price/Forward Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 83.78% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 23.82. USNA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.05 | ||
| Fwd PE | 8.52 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, USNA is valued cheaper than 97.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.64 |
4.3 Compensation for Growth
- USNA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- USNA's earnings are expected to grow with 21.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.45
PEG (5Y)N/A
EPS Next 2Y21.31%
EPS Next 3YN/A
5. USNA Dividend Analysis
5.1 Amount
- USNA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
USNA Fundamentals: All Metrics, Ratios and Statistics
NYSE:USNA (3/13/2026, 9:45:25 AM)
17.385
+0.18 (+1.02%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-17 2026-02-17/amc
Earnings (Next)04-20 2026-04-20/amc
Inst Owners58.34%
Inst Owner Change0.34%
Ins Owners0.65%
Ins Owner Change0.55%
Market Cap317.80M
Revenue(TTM)925.26M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (128.82%)
Short Float %3.99%
Short Ratio3.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)2.56%
EPS NY rev (3m)-4.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)4.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.05 | ||
| Fwd PE | 8.52 | ||
| P/S | 0.35 | ||
| P/FCF | N/A | ||
| P/OCF | 10.08 | ||
| P/B | 0.6 | ||
| P/tB | 1.29 | ||
| EV/EBITDA | 2.64 |
EPS(TTM)1.92
EY11.04%
EPS(NY)2.04
Fwd EY11.73%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY9.92%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)1.45
PEG (5Y)N/A
Graham Number35.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.34% | ||
| ROE | 3.22% | ||
| ROCE | 6.88% | ||
| ROIC | 5.43% | ||
| ROICexc | 7.14% | ||
| ROICexgc | 18.34% | ||
| OM | 4.58% | ||
| PM (TTM) | 1.86% | ||
| GM | 79.18% | ||
| FCFM | N/A |
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
ROICexc(3y)20.39%
ROICexc(5y)37.76%
ROICexgc(3y)38.56%
ROICexgc(5y)58.83%
ROCE(3y)12.43%
ROCE(5y)20.38%
ROICexgc growth 3Y-33.6%
ROICexgc growth 5Y-29.38%
ROICexc growth 3Y-44.57%
ROICexc growth 5Y-36.69%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
F-Score7
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 973.94% | ||
| Cap/Sales | 23.69% | ||
| Interest Coverage | 62.89 | ||
| Cash Conversion | 49.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1.46 | ||
| Altman-Z | 3.54 |
F-Score7
WACC8.55%
ROIC/WACC0.64
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-22.1%
EBIT growth 5Y-22.03%
EBIT Next Year32.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-381.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.2%
OCF growth 3YN/A
OCF growth 5YN/A
USANA HEALTH SCIENCES INC / USNA FAQ
What is the fundamental rating for USNA stock?
ChartMill assigns a fundamental rating of 5 / 10 to USNA.
Can you provide the valuation status for USANA HEALTH SCIENCES INC?
ChartMill assigns a valuation rating of 6 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.
Can you provide the profitability details for USANA HEALTH SCIENCES INC?
USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 5 / 10.
What is the financial health of USANA HEALTH SCIENCES INC (USNA) stock?
The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 8 / 10.
Can you provide the expected EPS growth for USNA stock?
The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 6.25% in the next year.